LCN2 and Sepsis: To evaluate whether the potentially beneficial effects of NGAL in-vivo have a significant impact on outcome during sepsis, we induced a highly lethal polymicrobial sepsis in mice and treated these with recombinant mouse Lipocalin-2 protein.